Evidence map›Paper›PMID 24323398›Full record

ArticleMedical oncology (Northwood, London, England)2014

Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cells.

K M Anderson, P Guinan, M Rubenstein

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

K M AndersonHektoen Research Institute, 627 S Wood Street, Chicago, IL, 60612, USA, kanderso427@sbcglobal.net.
P Guinan
M Rubenstein
Hektoen Institute · USUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A CD44/a 2 B 1- (CD41 integrin) and B-catenin-labeled fraction of PC3 prostate cancer cells is able to reconstitute cells representative of the original tumor in immuno-deficient mice (Li et al. in Cancer Res 68:1820-1825, 2008). After 48 h of culture under nitrogen with a resulting medium pH of 7.8, sorted hypoxic PC3 cells yielded a higher percentage and concentration/10(5) of cells in a doubly labeled (DL) CD44(+)/CD41(+) side fraction compared with control cells cultured under normoxia (5 % CO2 in the ambient atmosphere at 37 °C). When the rise in pH was prevented (95 % N2, 5 % CO2), the difference in sorted hypoxic cell numbers remained. Sorted N and H DL cells and CD44(+)/CD41(-) cells were cultured under standard conditions. After 1-2 weeks, the number of attached colonies from formerly hypoxic cells, whether previously cultured with N2 or 95 % N2 + 5 % CO2, exceeded the number of doubly labeled normoxic cells, consistent with their greater initial concentration. Cultured sorted N or H CD44(+)/CD41(-) cells resulted in monolayers containing a small percentage of DL cells. Recovery of greater percentage and numbers of putative cancer stem cells, confirmed by quantitative cell sorting after culture under hypoxic conditions, is consistent with their greater relative numbers present in hypoxic niches. In addition, the report that neither CD44(+) nor CD41(+) epitopes were preferentially associated with FAM65B(high)/MF12(low)/LEF1(low) PC3 cells able to reconstitute tumors in immuno-deficient mice (Zhang and Waxman in Mol Cancer 9:319-330, 2010) suggests an in vitro mimic of tumor cell heterogeneity observed in epithelial cancers.

Indexed as

AnimalsCell CountCell Culture TechniquesCell DifferentiationCell HypoxiaCell Line, TumorCell SeparationHumansHyaluronan ReceptorsHydrogen-Ion ConcentrationIntegrin alpha2IntegrinsMaleMiceNeoplastic Stem CellsOxygenCD44 protein, humanHyaluronan ReceptorsIntegrin alpha2IntegrinsITGA2B protein, humanOxygen

Identifiers

PMID24323398
OpenAlexW2104192609

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.